The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.
Northern High Yield Fixed Income NHFIX
- NAV / 1-Day Return 6.02 / +0.18 %
- Total Assets 2.7 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.600%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category High Yield Bond
- Credit Quality / Interest Rate Sensitivity Low/Limited
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 6.69%
- Effective Duration 3.33 years
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:17 PM GMT+0
Morningstar’s Analysis NHFIX
Will NHFIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 5.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Tenet Healthcare Corporation 4.375% | 0.85 | 22.2 Mil | Corporate |
CCO Holdings, LLC/ CCO Holdings Capital Corp. 5% | 0.84 | 21.8 Mil | Corporate |
Northern Institutional US Government | 0.81 | 21.1 Mil | Cash and Equivalents |
Venture Global LNG Inc. 9.5% | 0.58 | 15.3 Mil | Corporate |
ALVOGEN PHARMA US TL 4.75% 04/01/2022 | 0.57 | 14.8 Mil | Corporate |
Royal Caribbean Group 5.5% | 0.55 | 14.5 Mil | Corporate |
Venture Global LNG Inc. 8.375% | 0.53 | 13.8 Mil | Corporate |
Catalent Pharma Solutions, Inc. 3.5% | 0.51 | 13.2 Mil | Corporate |
AAdvantage Loyalty IP Ltd/ American Airlines Inc 5.75% | 0.51 | 13.2 Mil | Corporate |
Neptune BidCo US Inc. 9.29% | 0.50 | 13.0 Mil | Corporate |